October 15, 2020
Article
Only 29.5% of sampled CBD users claimed any wellness benefit.
October 01, 2020
This edition from the 10 Year Plan features perspective from leadership at ACC and ESC, as well as survey results from cardiologists.
September 30, 2020
Ongoing trials are essential to confirming semalutide’s role in decreasing risk of chronic kidney disease in patients with type 2 diabetes
September 03, 2020
At recommended adherence rates, automatic AI screening technology for diabetic retinopathy is a preferred strategy over conventional eye care professional screening.
September 02, 2020
For patients without diabetes, low serum bicarbonate and higher high sensitivity troponin T, NTproBNP, and urine NGAL were linked to a higher risk of the composite outcome.
September 01, 2020
Investigators report on a post-hoc analysis of the EMPA-REG OUTCOME trial that assesses the efficacy of the SGLT-2 inhibitor in patients with obstructive sleep apnea.
The new equation model has shown to be more accurate than the Framingham Lifetime Risk equation and Pooled Cohort Equation.
August 31, 2020
New data shows that high BMI individuals who were in the lowest polygenic score quintile had a 5-fold greater risk of diabetes than those with low BMI and a high polygenic score.
August 30, 2020
Dapagliflozin and empagliflozin are shown to minimize CV events in patients with heart failure and a reduced ejection fraction.
August 28, 2020
The system maintains tight glucose control and reduces the risk of hypoglycemia.
